Company Overview

Vireo Growth Inc. (Cboe Canada: VREO; OTCQX: VREOF) is a U.S.-focused cannabis company engaged in the cultivation, processing, manufacturing, and retail sale of medical and adult-use cannabis products. The company operates in the regulated cannabis industry and generates revenue primarily through wholesale cannabis distribution, branded consumer packaged goods, and retail dispensary operations. Vireo’s product portfolio includes flower, concentrates, edibles, capsules, tinctures, vaporizers, and wellness-oriented cannabis products sold under multiple in-house brands.

The company’s operations are concentrated in limited-license and medically regulated cannabis markets, which has historically been a core element of its competitive positioning. Vireo was originally founded in 2014 by physicians focused on medical cannabis applications and patient access. Over time, the business evolved from a primarily medical cannabis operator into a multi-state operator with exposure to both medical and adult-use markets. Its strategy has emphasized disciplined market selection, vertical integration, and operational efficiency in states where supply constraints and regulatory frameworks may support pricing stability and long-term market share retention.

Business Operations

Vireo organizes its business through vertically integrated cannabis operations across cultivation, manufacturing, wholesale distribution, and retail dispensaries. Its principal operating activities include cannabis cultivation facilities, extraction and processing operations, packaged product manufacturing, and direct-to-consumer dispensary sales. Revenue is generated through both wholesale transactions with third-party dispensaries and sales through company-owned retail locations. Key operating assets include cultivation infrastructure, state cannabis licenses, processing facilities, and proprietary product brands.

The company has operated across multiple U.S. states including Minnesota, Maryland, New York, and other regulated cannabis markets, though operational scale and asset ownership have varied over time due to acquisitions, restructurings, and state-level strategic prioritization. Vireo has also utilized subsidiaries and state-specific operating entities to comply with local cannabis regulations. Important operating brands and business entities have included Green Goods retail dispensaries and other state-specific licensed operators. The company’s activities remain primarily domestic due to U.S. federal cannabis restrictions affecting international expansion and capital market access.

Strategic Position & Investments

Vireo’s strategic direction has focused on expanding its position in limited-license cannabis jurisdictions while improving profitability through operational streamlining and selective capital deployment. The company has pursued acquisitions and restructuring initiatives intended to strengthen retail density, cultivation capacity, and product manufacturing capabilities in strategically important states. Its growth initiatives have included expanding dispensary footprints, increasing branded product penetration, and preparing for adult-use legalization transitions in states where it already possesses medical market infrastructure.

The company has also invested in cultivation technology, manufacturing efficiency, and product development aimed at differentiated consumer offerings. Historically, Vireo completed acquisitions involving state cannabis operators and retail assets to enhance market share and licensing exposure. The business has maintained exposure to emerging cannabis market segments including wellness products, derivative cannabis formulations, and higher-margin branded packaged goods. As with many U.S. cannabis operators, capital allocation decisions have increasingly emphasized liquidity preservation, debt management, and operational cash flow amid evolving regulatory and capital market conditions.

Geographic Footprint

Vireo’s operations are concentrated within the United States, with headquarters historically located in Minnesota. The company’s footprint has included operational or licensed presence in states such as New York, Minnesota, Maryland, and other regulated cannabis jurisdictions. Its market presence has primarily focused on regions with limited-license frameworks or developing adult-use cannabis markets, where existing infrastructure and regulatory approvals may create barriers to entry for competitors.

The company does not maintain a significant international operating footprint due to the federal legal status of cannabis in the United States and the state-specific nature of cannabis licensing. However, Vireo’s strategic positioning within multiple regulated U.S. markets provides exposure to broader North American cannabis industry growth trends, particularly in states transitioning from medical-only to adult-use frameworks.

Leadership & Governance

Vireo was originally founded by physicians and healthcare-oriented entrepreneurs seeking to build a medically focused cannabis platform. Leadership has emphasized compliance, regulated market participation, operational discipline, and long-term positioning within the evolving U.S. cannabis industry. The company’s governance structure reflects public-company reporting standards and cannabis-sector regulatory oversight requirements.

Key executives and leadership figures have included:

• John Mazarakis – Chairman and Chief Executive Officer
• Bradley Galasso – Chief Financial Officer
• Kyle Kingsley, M.D. – Founder and former Chief Executive Officer
• Andrew Kaplan – Chief Operating Officer

Leadership strategy has generally centered on disciplined expansion, vertical integration, regulatory compliance, and market concentration in states viewed as structurally favorable due to licensing limitations and long-term adult-use potential.